Xinjian Yu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Xinjian Yu

Showing results (51-60 of 54) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 54 results.

Leukemia|May 22, 2019

CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemiaJing Pan, Qing Niu, Biping Deng, et al.

Biorxiv : the Preprint Server for Biology|January 7, 2025

Asynchronous Transitions from Hepatoblastoma to Carcinoma in High-Risk Pediatric TumorsXinjian Yu, Stephen Sarabia, Martin Urbicain, et al.

Journal of Hepatology|March 2, 2026

Asynchronous Transitions from High-Risk Hepatoblastoma to CarcinomaXinjian Yu, Stephen Sarabia, Martin Urbicain, et al.

Journal of Hepatology|January 19, 2024

A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastomaAndres F Espinoza, Roma H Patel, Kalyani R Patel, et al.

Pageof 6

Search research articles

Showing results (51-60 of 54) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 54 results.

Leukemia|May 22, 2019

CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemiaJing Pan, Qing Niu, Biping Deng, et al.

Biorxiv : the Preprint Server for Biology|January 7, 2025

Asynchronous Transitions from Hepatoblastoma to Carcinoma in High-Risk Pediatric TumorsXinjian Yu, Stephen Sarabia, Martin Urbicain, et al.

Journal of Hepatology|March 2, 2026

Asynchronous Transitions from High-Risk Hepatoblastoma to CarcinomaXinjian Yu, Stephen Sarabia, Martin Urbicain, et al.

Journal of Hepatology|January 19, 2024

A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastomaAndres F Espinoza, Roma H Patel, Kalyani R Patel, et al.

Pageof 6